BIOT — Biotage AB Cashflow Statement
0.000.00%
Last trade - 00:00- SEK11.45bn
- SEK11.27bn
- SEK2.06bn
- 99
- 11
- 36
- 44
Annual cashflow statement for Biotage AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 223 | 269 | 348 | 303 | 328 |
| Depreciation | |||||
| Non-Cash Items | -11.7 | 4 | -17 | 14 | -18 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -5.92 | 5 | -92 | -182 | -82 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 279 | 353 | 341 | 284 | 413 |
| Capital Expenditures | -60.9 | -56 | -70 | -91 | -169 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.379 | -285 | -14 | 126 | -287 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -61.3 | -341 | -84 | 35 | -456 |
| Financing Cash Flow Items | — | — | -1 | — | — |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -22.7 | -82 | -133 | -142 | -156 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 185 | -61 | 131 | 153 | -160 |